SPECT Resources

Quality

• ASNC imaging guidelines for nuclear cardiology procedures - 2017
• Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease— state-of-the-evidence and clinical recommendations - 2017
• SPECT: Stress, Protocols, and Tracers - 2016
• SPECT: Stress, Protocols, and Tracers -2016 - Chinese Edition (Translated in 2017) - NEW
• First-Pass Radionuclide Angiography (FPRNA) - 2009 - Extended through 2015
• Equilibrium Radionuclide Angiocardiography (ERNA) - 2009- Extended through 2015
• Single Photon Emission Computed Tomography - 2010
• SIngle Photon Emission Computed Tomography - 2010- Chinese Edition (Translated in 2016)
• Single Photon Emission Computed Tomography - 2010 - Spanish Edition (Translated in 2014)
• Myocardial Perfusion Planar Imaging - 2009
• Standardized Reporting of Radionuclide Myocardial Perfusion and Function - 2009
• Single photon-emission computed tomography-2010
• Single Photon Emission Computed Tomography - 2010 - Spanish Edition/Tomografía por emisión de fotones únicos (SPECT) -(Translated in 2014)
• SIngle Photon Emission Computed Tomography (SPECT) - 2010- Chinese Edition -(Translated in 2016)

  Advocacy

  ASNC Model Coverage Policy for SPECT MPI (PDF)
  This document examines a variety of clinical indications and symptoms with which a common patient would present and supports the use of performing SPECT MPI by cross-referencing the indication with the multi-society appropriate use criteria for radionuclide studies developed by the American College of Cardiology (ACC) and ASNC in 2005, and subsequently revised in 2009. In addition, the use of SPECT MPI in patients with the indications delineated in the policy is supported by references to an abundance of literature which supports the use of this study in the provided scenarios. Finally, the document provides ICD-9 codes which correlate to each of the indications to demonstrate what codes, or range of codes, are appropriate for each clinical indication.

  Latest News

  Health Canada Approves Cardiac AdreView; Launch of ADMIRE-ICD Clinical Trial
  
   

  
  SPECT Resource Center Supported by Astellas Pharma US, Inc.